Guillem Pascual‐Pasto

GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity

Sabine Heitzeneder, Kristopher R. Bosse, Zhongyu Zhu et al. · Cancer Cell · 2021 · 163 citations · Full text

Medicine, Immunology, Oncology +17

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

Guillem Pascual‐Pasto, Miriam Bazán‐Peregrino, Nagore G. Olaciregui et al. · Science Translational Medicine · 2019 · 113 citations · Full text

Medicine, Oncology, Ophthalmology +16

A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression

Jing Liu, Daniela Ottaviani, Meriem Sefta et al. · Nature Communications · 2021 · 106 citations · Full text

Medicine, Genetics, Oncology +17

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

José Luis Ordóñez, Ana Teresa Amaral, Ángel M. Carcaboso et al. · Oncotarget · 2015 · 98 citations · Full text

Medicine, Oncology, Pharmacology +15

SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas

Guillem Pascual‐Pasto, Helena Castillo‐Ecija, Nora Unceta et al. · Journal of Controlled Release · 2021 · 53 citations

Medicine, Oncology, Pharmacology +13